Erin Lewis, DPM
Podiatrist · Kansas City, MONPI 1700348604
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,910 of the $3,691 with a category attached, or 78.8%. It is spread thinly across 22 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,729 and has fallen 85.9% since, to $244 in 2025.
Across 60 payments — averaging $61.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$879
- Stryker$598
- Nevro Corp.$389
- Johnson & Johnson$375
- Smith+Nephew$192
- Paragon 28, Inc.$159
- plus $1K from 16 others
What the payments were for
- Travel & lodging$78121%
- Food & beverage$2,91079%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 5 | $879 |
| Stryker | 9 | $598 |
| Nevro Corp. | 6 | $389 |
| Johnson & Johnson | 10 | $375 |
| Smith+Nephew | 5 | $192 |
| Paragon 28, Inc. | 1 | $159 |
| Organogenesis Inc. | 3 | $145 |
| Averitas Pharma Inc. | 1 | $122 |
| Edwards Lifesciences | 1 | $115 |
| Medline Industries LP | 1 | $110 |
| Paratek Pharmaceuticals, Inc. | 2 | $110 |
| Surgenex LLC | 1 | $104 |
| ANI Pharmaceuticals, Inc. | 2 | $62 |
| Next Science LLC | 1 | $56 |
| Mimedx Group, Inc. | 1 | $46 |
| Globus Medical | 2 | $46 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| Biotissue Holdings Inc. | 1 | $36 |
| Kerecis Limited | 1 | $28 |
| Bioventus LLC | 1 | $15 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALLOWRAP$317
- MOTOBAND$261
- AUGMENT INJECTABLE$161
- TENOTAC 2.0$159
- Omnia$150
- Senza$131
- MINIBUNION$130
- PuraPly$125
- Qutenza$122
- COLLAGENASE SANTYL$121
- PASCAL$115
- SurGraft$104
- SurMatrix$104
- ArdeoGraft$104
- PelloGraft$104
- RenoGraft$104
How this compares
$3,691 in reported general payments places this provider in the 70th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 35 | $336 |
| Methylprednisolone | 22 | $114 |
| Cephalexin | 16 | $51 |
| Prednisone | 16 | $35 |
| Meloxicam | 29 | $23 |
| Ibuprofen | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Kansas City
- Michael MarlingKansas City$9K
- Brian WareKansas City$4K
- Thomas BembynistaKansas City$3K
- Chengyu XieKansas City$970
- Luke SchmittKansas City$692
- William DukeJefferson City$54K
- Kiera Benge-SheaSaint Louis$28K
- Thomas BoldryLiberty$19K
- Ryan FrankIndependence$15K
- Neil ErmitanoSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.